|
1
|
Flis S and Chojnacki T: Chronic
myelogenous leukemia, a still unsolved problem: Pitfalls and new
therapeutic possibilities. Drug Des Devel Ther. 13:825–843.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gupta A and Khattry N: Current status of
hematopoietic stem cell transplant in chronic myeloid leukemia.
Indian J Med Paediatr Oncol. 35:207–210. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hino Y, Doki N, Yamamoto K, Senoo Y,
Sasajima S, Sakaguchi M, Hattori K, Kaito S, Kurosawa S, Harada K,
et al: Chronic myeloid leukemia relapsing ten years after allogenic
bone marrow transplantation. Rinsho Ketsueki. 57:608–612.
2016.PubMed/NCBI View Article : Google Scholar : (In Japanese).
|
|
4
|
Jabbour E and Kantarjian H: Chronic
myeloid leukemia: 2016 update on diagnosis, therapy, and
monitoring. Am J Hematol. 91:252–265. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ross DM, Arthur C, Burbury K, Ko BS, Mills
AK, Shortt J and Kostner K: Chronic myeloid leukaemia and tyrosine
kinase inhibitor therapy: Assessment and management of
cardiovascular risk factors. Intern Med J. 48 (Suppl 2):S5–S13.
2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li H, Liu L, Liu C, Zhuang J, Zhou C, Yang
J, Gao C, Liu G, Lv Q and Sun C: Deciphering key pharmacological
pathways of qingdai acting on chronic myeloid leukemia using a
network pharmacology-based strategy. Med Sci Monit. 24:5668–5688.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhang Y, Xiao Y, Dong Q, Ouyang W and Qin
Q: Neferine in the lotus plumule potentiates the antitumor effect
of imatinib in primary chronic myeloid leukemia cells in vitro. J
Food Sci. 84:904–910. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lv C, Huang Y, Liu ZX, Yu D and Bai ZM:
Salidroside reduces renal cell carcinoma proliferation by
inhibiting JAK2/STAT3 signaling. Cancer Biomark. 17:41–47.
2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Fan XJ, Wang Y, Wang L and Zhu M:
Salidroside induces apoptosis and autophagy in human colorectal
cancer cells through inhibition of PI3K/Akt/mTOR pathway. Oncol
Rep. 36:3559–3567. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shang H, Wang S, Yao J, Guo C, Dong J and
Liao L: Salidroside inhibits migration and invasion of poorly
differentiated thyroid cancer cells. Thorac Cancer. 10:1469–1478.
2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Qi Z, Tang T, Sheng L, Ma Y, Liu Y, Yan L,
Qi S, Ling L and Zhang Y: Salidroside inhibits the proliferation
and migration of gastric cancer cells via suppression of
Src-associated signaling pathway activation and heat shock protein
70 expression. Mol Med Rep. 18:147–156. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kang DY, Sp N, Kim DH, Joung YH, Lee HG,
Park YM and Yang YM: Salidroside inhibits migration, invasion and
angiogenesis of MDAMB 231 TNBC cells by regulating EGFR/Jak2/STAT3
signaling via MMP2. Int J Oncol. 53:877–885. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yu G, Li N, Zhao Y, Wang W and Feng XL:
Salidroside induces apoptosis in human ovarian cancer SKOV3 and
A2780 cells through the p53 signaling pathway. Oncol Lett.
15:6513–6518. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ren M, Xu W and Xu T: Salidroside
represses proliferation, migration and invasion of human lung
cancer cells through AKT and MEK/ERK signal pathway. Artif Cells
Nanomed Biotechnol. 47:1014–1021. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yang L, Yu Y, Zhang Q, Li X, Zhang C, Mao
T, Liu S and Tian Z: Anti-gastric cancer effect of Salidroside
through elevating miR-99a expression. Artif Cells Nanomed
Biotechnol. 47:3500–3510. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li H, Huang D and Hang S: Salidroside
inhibits the growth, migration and invasion of Wilms' tumor cells
through down-regulation of miR-891b. Life Sci. 222:60–68.
2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wu Y, Li J, Chen S and Yu Z: The effects
of miR-140-5p on the biological characteristics of ovarian cancer
cells through the Wnt signaling pathway. Adv Clin Exp Med.
29:777–784. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Fang Z, Yin S, Sun R, Zhang S, Fu M, Wu Y,
Zhang T, Khaliq J and Li Y: miR-140-5p suppresses the
proliferation, migration and invasion of gastric cancer by
regulating YES1. Mol Cancer. 16(139)2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Nie ZY, Liu XJ, Zhan Y, Liu MH, Zhang XY,
Li ZY, Lu YQ, Luo JM and Yang L: miR-140-5p induces cell apoptosis
and decreases Warburg effect in chronic myeloid leukemia by
targeting SIX1. Biosci Rep. 39(BSR20190150)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
StarBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Jin YL, Zhang XM, Chen X, Liu J, Chang YY,
Gao XY, Xue YM, Dong XS, Liu Y, Tian YY, et al: Salidroside induces
apoptosis via ERK1/2 in human leukemia. K562 cells. 9:17588–17595.
2016.
|
|
23
|
Qie S and Diehl JA: Cyclin D1, cancer
progression, and opportunities in cancer treatment. J Mol Med
(Berl). 94:1313–1326. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
El-Deiry WS: p21(WAF1) mediates cell-cycle
inhibition, relevant to cancer suppression and therapy. Cancer Res.
76:5189–5191. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Litwinska Z and Machalinski B: miRNAs in
chronic myeloid leukemia: Small molecules, essential function. Leuk
Lymphoma. 58:1297–1305. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Liao Y, Yin X, Deng Y and Peng X:
MiR-140-5p suppresses retinoblastoma cell growth via inhibiting
c-Met/AKT/mTOR pathway. Biosci Rep: Nov 30, 2018 (Epub ahead of
print). doi: 10.1042/BSR20180776.
|
|
27
|
Jia Q, Sun H, Xiao F, Sai Y, Li Q, Zhang
X, Yang S, Wang H, Wang H, Yang Y, et al: miR-17-92 promotes
leukemogenesis in chronic myeloid leukemia via targeting A20 and
activation of NF-κB signaling. Biochem Biophys Res Commun.
487:868–874. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cai H, Qin X and Yang C: Dehydrocostus
lactone suppresses proliferation of human chronic myeloid leukemia
cells through Bcr/Abl-JAK/STAT signaling pathways. J Cell Biochem.
118:3381–3390. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li L, Qi Y, Ma X, Xiong G, Wang L and Bao
C: TRIM22 knockdown suppresses chronic myeloid leukemia via
inhibiting PI3K/Akt/mTOR signaling pathway. Cell Biol Int.
42:1192–1199. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Huang L, Huang Z, Lin W, Wang L, Zhu X,
Chen X, Yang S and Lv C: Salidroside suppresses the growth and
invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by
inhibiting the JAK2/STAT3 signaling pathway. Int J Oncol.
54:1969–1980. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhao J, Du X, Wang M, Yang P and Zhang J:
Salidroside mitigates hydrogen peroxide-induced injury by
enhancement of microRNA-27a in human trabecular meshwork cells.
Artif Cells Nanomed Biotechnol. 47:1758–1765. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Cha Y, He Y, Ouyang K, Xiong H, Li J and
Yuan X: MicroRNA-140-5p suppresses cell proliferation and invasion
in gastric cancer by targeting WNT1 in the WNT/β-catenin signaling
pathway. Oncol Lett. 16:6369–6376. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Han XR, Wen X, Wang YJ, Wang S, Shen M,
Zhang ZF, Fan SH, Shan Q, Wang L, Li MQ, et al: MicroRNA-140-5p
elevates cerebral protection of dexmedetomidine against
hypoxic-ischaemic brain damage via the Wnt/β-catenin signalling
pathway. J Cell Mol Med. 22:3167–3182. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhao G, Yin Y and Zhao B: miR-140-5p is
negatively correlated with proliferation, invasion, and
tumorigenesis in malignant melanoma by targeting SOX4 via the
Wnt/β-catenin and NF-κB cascades. J Cell Physiol. 235:2161–2170.
2020.PubMed/NCBI View Article : Google Scholar
|
